CLINICAL TRIALS PROFILE FOR TECARFARIN
✉ Email this page to a colleague
Clinical Trials for Tecarfarin
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT02522221 ↗ | Tecarfarin Anti-Coagulation Trial (TACT) | Unknown status | Armetheon Inc | Phase 3 | TACT is a "real world" randomized controlled trial of tecarfarin, a novel vitamin K antagonist, vs. warfarin. The quality of anticoagulation control will be compared for the two groups of subjects who require chronic oral anticoagulation for a broad panel of indications. |
NCT02522221 ↗ | Tecarfarin Anti-Coagulation Trial (TACT) | Unknown status | Espero Biopharma | Phase 3 | TACT is a "real world" randomized controlled trial of tecarfarin, a novel vitamin K antagonist, vs. warfarin. The quality of anticoagulation control will be compared for the two groups of subjects who require chronic oral anticoagulation for a broad panel of indications. |
NCT03652779 ↗ | A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers | Completed | Lee's Pharmaceutical Limited | Phase 1 | The purpose of the study is to evaluate the safety and tolerability of a single dose of tecarfarin in healthy Chinese Volunteers. the Pharmacokinetic and pharmacodynamic profile of tecarfarin will also be evaluated. |
NCT04627116 ↗ | An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers | Enrolling by invitation | Lee's Pharmaceutical Limited | Phase 1 | The subjects will be admitted to the Phase I Clinical Research Center on day -1. Subjects received once-daily doses of Tecarfarin for up to 14 days.Subjects can leave the Phase I Clinical Research Center on the day 21.And returned to the research center for follow-up on the day 28 and 35. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Tecarfarin
Condition Name
Clinical Trial Locations for Tecarfarin
Clinical Trial Progress for Tecarfarin
Clinical Trial Phase
Clinical Trial Sponsors for Tecarfarin
Sponsor Name